Oncology Intelligence (OI) Suite
Oncology Biomarker Discovery & Patient Stratification
Commercial/Research-UseActive
Key Facts
Indication
Oncology Biomarker Discovery & Patient Stratification
Phase
Commercial/Research-Use
Status
Active
Company
About Imagene AI
Imagene AI, founded in 2020, is a private, early-revenue stage company developing a proprietary Cross-Modality Intelligence Engine for precision oncology. Its SaaS platform, the Oncology Intelligence (OI) Suite, leverages AI on histopathology images and multimodal data to accelerate biomarker discovery, patient stratification, and trial optimization. The company has established key partnerships with industry leaders like Tempus and Oracle Cloud Infrastructure to deploy its technology, positioning it at the intersection of AI diagnostics and biopharma R&D.
View full company profile